The 68th China National Pharmaceutical Machinery Exposition and the 2026 China International Pharmaceutical Machinery Exposition (CIPM) will take place October 27–29, 2026, at the Xiamen International Expo Center. The exhibition brings together leading pharmaceutical equipment manufacturers and cutting-edge technologies from around the world, serving as an annual bellwether for technology trends in the pharmaceutical industry.

Advancing Pharmaceutical Manufacturing Through Expertise and Innovation

The global pharmaceutical industry is moving toward more efficient, continuous, digitalized, and sustainable manufacturing. Advances in innovative therapies are creating new demands on production processes, while pharmaceutical companies face increasing pressure to boost efficiency, reduce resource consumption, shorten R&D timelines, and bring products to market faster. As a specialized provider of core equipment, process systems, and total plant solutions, Morimatsu brings extensive experience in pharmaceutical manufacturing. We are committed to tackling key industry challenges, showcasing innovative applications, and creating value across the pharmaceutical manufacturing value chain.

Innovative Solutions for Evolving Industry Needs

At this year's exhibition, Morimatsu will showcase a broad portfolio of solutions and services tailored to real-world industry needs and backed by practical experience. Through innovative concepts and designs, we look forward to exchanging ideas with industry professionals and exploring new opportunities for pharmaceutical manufacturing.

1.Total Laboratory Solution

Bioengineering's upstream cell culture solutions, combined with Morimatsu's downstream separation and purification technologies, support key stages of the bioprocessing journey from laboratory research and development to commercial-scale production.

2.Single-Use Solutions

With advantages of speed, flexibility, and low cross-contamination risk, it enables efficient and adaptable biopharmaceutical production.

3.Formulation Solution

With flexible, customized designs to accommodate different process requirements and dosage forms, our formulation production lines support efficient, reliable manufacturing.

4.Solid Preparation and API Process Solutions

Our solutions address process requirements for solid dosage forms and active pharmaceutical ingredients (APIs), helping improve production efficiency and facilitate the transition from R&D to manufacturing.

5.Digital Intelligent Solution

Unattended operation helps reduce the risk of cross-contamination at the source while maintaining process consistency, enabling more efficient manufacturing and supporting continued process innovation.

There's more to discover beyond the technology. Stop by the Morimatsu booth to enjoy interactive robot demonstrations, participate in prize drawings, and add a little extra excitement to your exhibition experience.

See You in Xiamen This October!

Let's turn practical experience into new insights

and meaningful conversations into fresh ideas for the future.

We look forward to connecting with you at CIPM 2026!

About Morimatsu LifeSciences

Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.

Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.

Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.

Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.

As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.